In vitro growth suppression by adenoviral transduction of p21 and p16 in squamous cell carcinoma of the head and neck: A research model for combination gene therapy

Archives of Otolaryngology - Head and Neck Surgery

Volumn 124, Issue 1, 1998, Pages 88-92

  Mobley, Steven Ross ^a   Liu, Ta Jen ^a   Hudson, J Michael ^a   Clayman, Gary L ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; GENE PRODUCT; PROTEIN P16; PROTEIN P21; VIRUS VECTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL CYCLE; CONTROLLED STUDY; GENE THERAPY; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; SQUAMOUS CELL CARCINOMA;

EID: 0031933739     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.124.1.88     Document Type: Article

References (16)

1. Anderson, WF. End-of-the-year potpourri. Hum Gene Ther 1996;7:2201-2202.
2. Liu TJ, Zhang WW, Taylor DL, Roth JA, Goepfert H, Clayman GL. Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus. Cancer Res. 1994;54:3662-3667.
3. Liu TJ, El-Naggar AK, McDonnell TJ, et al. Apoptosis induction mediated by wild-type p53 adenoviral gene transfer in squamous cell carcinoma of the head and neck. Cancer Res. 1995;55:3117-3122.
4. Clayman GL, El-Naggar AK, Roth JA, et al. In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma. Cancer Res. 1995;55:1-6.
5. Weinberg RA. Tumor suppressor genes. Science. 1992;254:1138-1145.
6. Serrano M, Hannon G, Beach D. A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK 4, Nature. 1993;366:704-707.
7. INK4 in human cancer. Proc Natl Acad Sci U S A. 1994;91:11045-11049.
8. Mori T, Miura K, Aoki T, Nishihira T, Mori S, Nakamura Y. Frequent somatic mutations of the MTS1/CDK41 (multiple tumor suppressor/cyclin dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res. 1994; 54:3396-3397.
9. Eastham JA, Hall SJ, Sehgal I, et al. In vivo gene therapy with p53 or p21 adenovirus for prostate cancer. Cancer Res. 1995;55:5151-5155.
10. 1 arrest in human cancer cells. Cancer Res. 1995;55:5187-5190.
11. 1 cyclin-dependent kinases. Cell. 1993;75: 805-816.
12. Harper JW, Elledge SJ, Keyomarsi K, et al. Inhibition of cyclin dependent kinases by p21. Mol Biol Cell. 1995;6:387-400.
13. 1 checkpoint function. Cell. 1995;82:675-684.
14. WAF1. Cancer Res. 1995;55:4536-4539.
15. Baisch H, Gohde W, Linden, WA. Analysis of PCP-data to determine the fraction of cells in the various phases of cell cycle. Radiat Environ Biophys. 1975;12:31-39.
16. INK4 gene mediated by an adenovirus vector. Cancer Res. 1995;55:3250-3253.